Merck, MAB8671B, Anti-Influenza B Antibody, Core, clone 22D5-12-13, biotin-conjugated

Immunogen
Epitope: Core
Application
Anti-Influenza B Antibody, Core, clone 22D5-12-13, biotin-conjugated detects level of Influenza B & has been published & validated for use in IF.
Indirect Immunofluorescence

Optimal dilutions must be determined by end user.
Research Category
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Biochem/physiol Actions
Influenza B, anti-core specific; reacts with all strains of Influenza B tested. No reactivity with Flu A or other respiratory viruses.
Physical form
Biotin conjugated purified immunoglobulin. Liquid in 0.01M PBS, pH=7.1, 0.1% Sodium Azide with 15 mg/mL BSA as stabilizer.
Preparation Note
Store at 2° to 8°C for up to 12 months from date of receipt. Protect from light.
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.